A Study Comparing Tazarotene Cream 0.05% to TAZORAC® (Tazarotene) Cream 0.05% and Both to a Placebo Control in the Treatment of Plaque Psoriasis
Public ClinicalTrials.gov record NCT02886702. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing Tazarotene Cream 0.05% to TAZORAC® (Tazarotene) Cream 0.05% and Both Active Treatments to a Vehicle Control in the Treatment of Stable Plaque Psoriasis
Study identification
- NCT ID
- NCT02886702
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Fougera Pharmaceuticals Inc.
- Industry
- Enrollment
- 855 participants
Conditions and interventions
Conditions
Interventions
- Tazarotene Cream 0.05% Drug
- TAZORAC® (tazarotene) Cream 0.05% Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 18, 2016
- Primary completion
- Aug 1, 2017
- Completion
- Aug 1, 2017
- Last update posted
- Aug 28, 2018
2016 – 2017
United States locations
- U.S. sites
- 30
- U.S. states
- 15
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Fougera Investigational Site | Phoenix | Arizona | 85018 | — |
| Fougera Investigational Site | Hot Springs | Arkansas | 71913 | — |
| Fougera Investigational Site | Anaheim | California | 92801 | — |
| Fougera Investigational Site | North Hollywood | California | 91606 | — |
| Fougera Investigational Site | San Diego | California | 92108 | — |
| Fougera Investigational Site | San Ramon | California | 94582 | — |
| Fougera Investigational Site | Brandon | Florida | 33511 | — |
| Fougera Investigational Site | Coral Gables | Florida | 33134 | — |
| Fougera Investigational Site | Hialeah | Florida | 33016 | — |
| Fougera Investigational Site | Miami | Florida | 33015 | — |
| Fougera Investigational Site | Miami | Florida | 33143 | — |
| Fougera Investigational Site | Miami | Florida | 33175 | — |
| Fougera Investigational Site | Miami Gardens | Florida | 33169 | — |
| Fougera Investigational Site | Miramar | Florida | 33027 | — |
| Fougera Investigational Site | Sweetwater | Florida | 33172 | — |
| Fougera Investigational Site | Tampa | Florida | 33618 | — |
| Fougera Investigational Site | West Palm Beach | Florida | 33406 | — |
| Fougera Investigational Site | Macon | Georgia | 31217 | — |
| Fougera Investigational Site | Arlington Heights | Illinois | 60005 | — |
| Fougera Investigational Site | New Albany | Indiana | 47150 | — |
| Fougera Investigational Site | Plainfield | Indiana | 46168 | — |
| Fougera Investigational Site | Louisville | Kentucky | 40202 | — |
| Fougera Investigational Site | Lake Charles | Louisiana | 70605 | — |
| Fougera Investigational Site | Saint Joseph | Missouri | 91606 | — |
| Fougera Investigational Site | Henderson | Nevada | 89052 | — |
| Fougera Investigational Site | High Point | North Carolina | 27262 | — |
| Fougera Investigational Site | Salem | Oregon | 97302 | — |
| Fougera Investigational Site | Hazleton | Pennsylvania | 18201 | — |
| Fougera Investigational Site | Upper Saint Clair | Pennsylvania | 15241 | — |
| Fougera Investigational Site | San Antonio | Texas | 78207 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02886702, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 28, 2018 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02886702 live on ClinicalTrials.gov.